Advisory Caution Message on Retail Packaging of Levothyroxine and Its Significance in the Treatment of Hypothyroidism

preprint OA: closed CC-BY-4.0
🔓 Open OA copy View at publisher

Abstract

Levothyroxine is extensively used for overt hypothyroidism. Most of the time, it is also prescribed by general practitioners in developing countries for subclinical hypothyroidism at the initial stages, despite adequate recommendations for the treatment, causing the manifestation of new health disorders. Therefore, it is opined that an advisory caution message should be inscribed on the retail packaging of Levothyroxine to give an indication to the non-endocrinologist general practitioner about the correct treatment protocol and to make the patient aware as well.

My notes (saved in your browser only)

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

europepmc
last seen: 2026-05-19T01:45:01.086888+00:00
unpaywall
last seen: 2026-05-20T11:00:21.680559+00:00
License: CC-BY-4.0